The Western blot assay confirmed a significantly elevated p-TAZ, p-YAP, and LATS2 in renal fibrosis samples transfected with miR-4709-3p-inhibitors compared to the sham group (Figure 5(a)). This evidence concerns the gene LATS2 and renal fibrosis.